Vaginal Candidacies or vaginal candidial infection is one of the most common infections in reproductive age and older age woman. It is usually managed by first line treatment of azoles and other antifungal antibiotics through oral, tropical and intra-vaginal preparations. Followed by if recurrence observed, intravenous preparation also administrated. During the past decades, the incidence of vaginal candidiasis and recurrent vaginal Candidiasis was frequently occurred due to poor/ mis-diagnosis, development of drug resistance, infection by non albicans species, phenotypic and genetic adaptation towards the drug Candidate. Even though, there are enormous new antifungal antibiotics was introduced but the incidence of drug resistance was more concern. So in order to overcome this circumstance the researchers are tend to make a new Candida to prevent the Candida infection. In this review we are trying to achieve the importance Candida vaccine thus should provide a better option for candidiasis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.